Just when the medical community is becoming excited about PET for Alzheimer's disease, along comes a new nemesis, the scratch-and-sniff test. Apparently, in Alzheimer's, the nose knows.
Just when the medical community is becoming excited about PET for Alzheimer's disease, along comes a new nemesis, the scratch-and-sniff test. Apparently, in Alzheimer's, the nose knows.
Autopsy results have indicated that the nerve pathways involved in smell are affected at an early stage in the brains of Alzheimer's pa-tients. Researchers at Columbia University have pinpointed 10 specific odors that patients with early Alzheimer's cannot identify: clove, leather, lemon, lilac, menthol, natural gas, pineapple, smoke, soap, and strawberry. The inability to identify these specific odors predicted who would go on to develop AD, according to Dr. Davangere Devanand and colleagues, who presented the findings at the American Col-lege of Neuropsychopharmacology meeting in December.
Devanand had ear-lier found a global relationship between loss of smell and Alzheimer's. But knowing the specific odors involved can help physicians make a definitive diagnosis and start therapy earlier, he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.